These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34686549)

  • 1. Paediatric tuberculosis preventive treatment preferences among HIV-positive children, caregivers and healthcare providers in Eswatini: a discrete choice experiment.
    Hirsch-Moverman Y; Strauss M; George G; Mutiti A; Mafukidze A; Shongwe S; Dube GS; El Sadr WM; Mantell JE; Howard AA
    BMJ Open; 2021 Oct; 11(10):e048443. PubMed ID: 34686549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TB preventive therapy preferences among children and adolescents.
    Strauss M; Wademan DT; Mcinziba A; Hoddinott G; Rafique M; Jola LN; Streicher C; du Preez K; Osman M; Boffa J; Hausler H; Hesseling AC; Hirsch-Moverman Y
    Int J Tuberc Lung Dis; 2023 Jul; 27(7):520-529. PubMed ID: 37353873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. They do not have symptoms - why do they need to take medicines? Challenges in tuberculosis preventive treatment among children in Cambodia: a qualitative study.
    An Y; Teo AKJ; Huot CY; Tieng S; Khun KE; Pheng SH; Leng C; Deng S; Song N; Nonaka D; Yi S
    BMC Pulm Med; 2023 Mar; 23(1):83. PubMed ID: 36899328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gaps in the tuberculosis preventive therapy care cascade in children in contact with TB.
    Van Ginderdeuren E; Bassett J; Hanrahan CF; Mutunga L; Van Rie A
    Paediatr Int Child Health; 2021 Nov; 41(4):237-246. PubMed ID: 34533111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis.
    Uppal A; Rahman S; Campbell JR; Oxlade O; Menzies D
    PLoS Med; 2021 Sep; 18(9):e1003712. PubMed ID: 34520463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vikela Ekhaya: A Novel, Community-based, Tuberculosis Contact Management Program in a High Burden Setting.
    Kay AW; Sandoval M; Mtetwa G; Mkhabela M; Ndlovu B; Devezin T; Sikhondze W; Vambe D; Sibanda J; Dube GS; Stevens RH; Lukhele B; Mandalakas AM
    Clin Infect Dis; 2022 May; 74(9):1631-1638. PubMed ID: 34302733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The social implications of participant choice on adherence to Isonaizid Preventive Therapy (IPT): A follow-up study to high completion rates in Eswatini.
    Grande SW; Adams LV; Maseko TSB; Talbot EA; deGijsel D; Mikal J; Simelane ZZ; Achili A; Mkhontfo M; Haumba SM
    PLoS One; 2020; 15(5):e0232841. PubMed ID: 32469990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferences of people living with HIV for features of tuberculosis preventive treatment regimens - a discrete choice experiment.
    Aschmann HE; Musinguzi A; Kadota JL; Namale C; Kakeeto J; Nakimuli J; Akello L; Welishe F; Nakitende A; Berger C; Dowdy DW; Cattamanchi A; Semitala FC; Kerkhoff AD
    medRxiv; 2023 Sep; ():. PubMed ID: 37745521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of pill counting on resource-limited health facilities: a thematic qualitative analysis in eSwatini.
    Krezanoski JD; Matshotyana K; Nxumalo N; Comfort AB; Khumalo P; Krezanoski PJ
    Health Policy Plan; 2020 May; 35(4):452-460. PubMed ID: 32073622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania.
    Hunter OF; Kyesi F; Ahluwalia AK; Daffé ZN; Munseri P; von Reyn CF; Adams LV
    BMC Infect Dis; 2020 Oct; 20(1):738. PubMed ID: 33028260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis.
    Yanes-Lane M; Ortiz-Brizuela E; Campbell JR; Benedetti A; Churchyard G; Oxlade O; Menzies D
    PLoS Med; 2021 Sep; 18(9):e1003738. PubMed ID: 34520459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis preventive treatment preferences among care givers of children in Lesotho: a pilot study.
    Hirsch-Moverman Y; Mantell JE; Lebelo L; Wynn C; Hesseling AC; Howard AA; Nachman S; Frederix K; Maama LB; El-Sadr WM
    Int J Tuberc Lung Dis; 2018 Aug; 22(8):858-862. PubMed ID: 29991393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of interventions to improve diagnosis and preventive therapy for paediatric tuberculosis in 9 sub-Saharan African countries: A modelling study.
    Mafirakureva N; Mukherjee S; de Souza M; Kelly-Cirino C; Songane MJP; Cohn J; Lemaire JF; Casenghi M; Dodd PJ
    PLoS Med; 2023 Sep; 20(9):e1004285. PubMed ID: 37672524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of suboptimal adherence to isoniazid preventive therapy among adolescents and children living with HIV.
    Kay AW; Thivalapill N; Skinner D; Dube GS; Dlamini N; Mzileni B; Fuentes P; Ustero P; Adams LV; Mandalakas AM
    PLoS One; 2020; 15(12):e0243713. PubMed ID: 33332462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating 3HP-based tuberculosis preventive treatment into Zimbabwe's Fast Track HIV treatment model: experiences from a pilot study.
    Mapingure MP; Zech JM; Hirsch-Moverman Y; Msukwa M; Howard AA; Makoni T; Gwanzura C; Apollo T; Sandy C; Musuka GN; Rabkin M
    J Int AIDS Soc; 2023 Jun; 26(6):e26105. PubMed ID: 37339341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-based tuberculosis contact management: Caregiver experience and factors promoting adherence to preventive therapy.
    Sandoval M; Mtetwa G; Devezin T; Vambe D; Sibanda J; Dube GS; Dlamini-Simelane T; Lukhele B; Mandalakas AM; Kay A
    PLOS Glob Public Health; 2023; 3(7):e0001920. PubMed ID: 37450473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the tuberculosis case-finding and prevention cascade among people living with HIV in Zambia - 2018: a cross-sectional cluster survey.
    Melgar M; Shiraishi RW; Tende C; Mwanza S; Mulenga J; Khondowe S; Mwakazanga D; Kapungu K; Tembo M; Nota A; Lungu P; Moore B; Podewils LJ
    BMC Public Health; 2021 May; 21(1):859. PubMed ID: 33947361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of women-led community interventions in improving tuberculosis preventive treatment in children: results from a comparative, before-after study in Ethiopia.
    Jerene D; Assefa D; Tesfaye K; Bayu S; Seid S; Aberra F; Bedru A; Khan A; Creswell J
    BMJ Open; 2022 Jul; 12(7):e062298. PubMed ID: 35863840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gaps in TB preventive therapy for persons initiating antiretroviral therapy in Uganda: an explanatory sequential cascade analysis.
    Kalema N; Semeere A; Banturaki G; Kyamugabwa A; Ssozi S; Ggita J; Kabajaasi O; Kambugu A; Kigozi J; Muganzi A; Castelnuovo B; Cattamanchi A; Armstrong-Hough M
    Int J Tuberc Lung Dis; 2021 May; 25(5):388-394. PubMed ID: 33977907
    [No Abstract]   [Full Text] [Related]  

  • 20. Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness.
    Nsengiyumva NP; Campbell JR; Oxlade O; Vesga JF; Lienhardt C; Trajman A; Falzon D; Den Boon S; Arinaminpathy N; Schwartzman K
    PLoS Med; 2022 Jun; 19(6):e1004032. PubMed ID: 35696431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.